The CDC is meeting today to discuss new limits on Johnson & Johnson’s COVID-19 vaccine over blood clotting issues:
Expert advisers to the CDC will discuss what U.S. health officials see as a concerning increase in the rates of a rare blood clotting disorder linked to Johnson & Johnson’s Covid vaccine. https://t.co/OudThaS19T
— The New York Times (@nytimes) December 16, 2021
According to the Washington Post, “the highest reporting rate of clot issues — about one case per 100,000 doses administered — has been in women 30 to 49 years old”:
If your Dr doesn’t consider natural immunity when advising whether risks of the vax outweigh benefits, I’d find a new Dr.
“the highest reporting rate of clot issues — about one case per 100,000 doses administered — has been in women 30 to 49 years old.”https://t.co/MDgKd5FTel
— Thomas Massie (@RepThomasMassie) December 16, 2021
And these issues have “increased since April”:
J&J vaccine: New data appears to show the rate of blood clot issues has increased since April, although the "problem remains rare."https://t.co/nWpYwtvWop
— Disclose.tv (@disclosetv) December 16, 2021
They were warned?
8 Months ago, I said the CDC should advise against J&J to women <50 — mRNA was a safer, available alternative 👇👇
Needless cases of VITT later, they slowly move in this directionhttps://t.co/LXLFOJU5mG https://t.co/EokSEAQfTW pic.twitter.com/DaLRTTMIb2
— Vinay Prasad, MD MPH 🎙️📷 (@VPrasadMDMPH) December 16, 2021
We’ll keep you posted.
To change your comments display name, click here.